In a seismic shift for consumer healthcare, household goods titan Kimberly-Clark is reportedly in advanced discussions to acquire Kenvue, the company behind Tylenol and Band-Aid, in a deal that could reshape the global market.
Former President Donald Trump's confusion between Tylenol and hydroxychloroquine during the presidential debate triggers a sharp sell-off in pharmaceutical stocks, with Kenvue shares taking a significant hit.
Pharmaceutical giant Kenvue has issued a stern rebuke to Donald Trump after he suggested the COVID-19 vaccine was comparable to the Tylenol murders, calling the analogy 'irresponsible'.